Arik Hasson

Dr‭. ‬Hasson was Kadimastem‭ ‬’s first employee when it was founded in fall of 2009‭. ‬Prior to Kadimastem‭, ‬Dr‭. ‬Hasson was the head of Stem Cell Projects in Gamida Cell‭, ‬a stem cell therapeutic company‭. ‬While at Gamida Cell‭, ‬Dr‭. ‬Hasson also headed the diabetic and neurological projects‭.‬

In addition‭, ‬Dr‭. ‬Hasson helped to initiate and served as the R&D Director of the Israeli Consortium for Stem Cells R&D‭ (‬“Bereshit”‭), ‬a consortium funded by the Chief Scientist in the Israeli Office of Industry‭, ‬Trade‭ ‬&‭ ‬Labor‭. ‬Prior to these roles‭, ‬Dr‭. ‬Hasson‭ ‬was head of Development in Gamida Cell and helped developing its first Cell Therapy product‭, ‬StemEx®‭ ‬into clinical trial‭ (‬Currently completing phase III clinical trials for treatment of hematological malignancies‭).‬

Dr‭. ‬Hasson holds a PhD in cellular neurobiology from the Hebrew University of Jerusalem‭, ‬and did a post-doctoral research in the‭ ‬Biotechnology Laboratory‭, ‬University of British Columbia‭, ‬Vancouver‭, ‬BC‭, ‬Canada‭. ‬He is the author of tens of peered review papers in the fields of stem cell‭, ‬cell therapy and neurobiology and of 17‭ ‬patents in these fields‭.